Significant inhibition of infantile hemangioma growth by sustained delivery of urea from liposomes-in-microspheres.

about

Significant inhibition of infantile hemangioma growth by sustained delivery of urea from liposomes-in-microspheres.

Item

http://www.wikidata.org/entity/Q49384897

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Significant inhibition of infa ...... rom liposomes-in-microspheres.

@en

Significant inhibition of infa ...... rom liposomes-in-microspheres.

@nl

type

Item

label

Significant inhibition of infa ...... rom liposomes-in-microspheres.

@en

Significant inhibition of infa ...... rom liposomes-in-microspheres.

@nl

prefLabel

Significant inhibition of infa ...... rom liposomes-in-microspheres.

@en

Significant inhibition of infa ...... rom liposomes-in-microspheres.

@nl

P1476

Significant inhibition of infa ...... rom liposomes-in-microspheres.

@en

P2093

Changxian Dong

http://www.w3.org/2001/XMLSchema#string

Dakan Liu

http://www.w3.org/2001/XMLSchema#string

Jin Sun

http://www.w3.org/2001/XMLSchema#string

Xiaonan Guo

http://www.w3.org/2001/XMLSchema#string

Xiaoshuang Zhu

http://www.w3.org/2001/XMLSchema#string

Yubin Gong

http://www.w3.org/2001/XMLSchema#string

P2860

Fabrication and characterizations of a novel drug delivery device liposomes-in-microsphere (LIM).

Physicochemical characterization of colloidal drug delivery systems such as reverse micelles, vesicles, liquid crystals and nanoparticles for topical administration.

Biodegradation and biocompatibility of PLA and PLGA microspheres.

Rapamycin inhibits proliferation of hemangioma endothelial cells by reducing HIF-1-dependent expression of VEGF.

Urea immunoliposome inhibits human vascular endothelial cell proliferation for hemangioma treatment.

Polymer microspheres for controlled drug release.

Hypoxia-inducible factor 1: regulation by hypoxic and non-hypoxic activators.

Infantile hemangiomas: how common are they? A systematic review of the medical literature.

The Role of the Pharmacist in the Treatment of Patients with Infantile Hemangioma Using Propranolol.

Safety assessment of nanomaterials: implications for nanomedicine.

P304

109-118

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OR.2017.6103

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29192323

http://www.w3.org/2001/XMLSchema#string

P921

microspheres

P932

5783591

http://www.w3.org/2001/XMLSchema#string